DISCRIMINATIVE STIMULUS PROPERTIES OF PHENYLISOPROPYLAMINE DERIVATIVES

被引：32
作者：
GLENNON, RA
机构：
来源：
DRUG AND ALCOHOL DEPENDENCE | 1986年 / 17卷 / 2-3期
关键词：
D O I：
10.1016/0376-8716(86)90003-7
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：119 / 134
页数：16
相关论文
共 16 条
[1]   1-(2,3-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE (2,3-MDA) - A PRELIMINARY INVESTIGATION [J].
GLENNON, RA ;
YOUNG, R ;
SOINE, W .
GENERAL PHARMACOLOGY, 1984, 15 (04) :361-362
[2]  
GLENNON RA, 1982, BIOL PSYCHIAT, V17, P807
[3]   FURTHER INVESTIGATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF MDA [J].
GLENNON, RA ;
YOUNG, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 20 (04) :501-505
[4]   STRUCTURE-ACTIVITY STUDIES ON AMPHETAMINE ANALOGS USING DRUG DISCRIMINATION METHODOLOGY [J].
GLENNON, RA ;
YOUNG, R ;
HAUCK, AE ;
MCKENNEY, JD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 21 (06) :895-901
[5]   COMPARISON OF BEHAVIORAL PROPERTIES OF DI-METHOXYPHENYLISOPROPYLAMINE AND TRI-METHOXYPHENYLISOPROPYLAMINE [J].
GLENNON, RA ;
YOUNG, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 17 (04) :603-607
[6]   MDA - A PSYCHOACTIVE AGENT WITH DUAL STIMULUS EFFECTS [J].
GLENNON, RA ;
YOUNG, R .
LIFE SCIENCES, 1984, 34 (04) :379-383
[7]   DISCRIMINATIVE STIMULUS PROPERTIES OF S(-)-CATHINONE AND R(+)-CATHINONE, (+)-CATHINE AND SEVERAL STRUCTURAL MODIFICATIONS [J].
GLENNON, RA ;
SCHECHTER, MD ;
ROSECRANS, JA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 21 (01) :1-3
[8]   BEHAVIORAL AND SEROTONIN RECEPTOR PROPERTIES OF 4-SUBSTITUTED DERIVATIVES OF THE HALLUCINOGEN 1-(2,5-DIMETHOXYPHENYL)-2-AMINOPROPANE [J].
GLENNON, RA ;
YOUNG, R ;
BENINGTON, F ;
MORIN, RD .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1163-1168
[9]   INDOLEALKYLAMINE AND PHENALKYLAMINE HALLUCINOGENS - EFFECT OF ALPHA-METHYL AND N-METHYL SUBSTITUENTS ON BEHAVIORAL ACTIVITY [J].
GLENNON, RA ;
YOUNG, R ;
JACYNO, JM .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (07) :1267-1273
[10]   MDA - AN AGENT THAT PRODUCES STIMULUS EFFECTS SIMILAR TO THOSE OF 3,4-DMA, LSD AND COCAINE [J].
GLENNON, RA ;
YOUNG, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) :249-250
12